Imperial College London

Professor Nicholas Simmonds

Faculty of MedicineNational Heart & Lung Institute

Professor of Practice (Respiratory Medicine)



+44 (0)20 7351 8997n.simmonds




Dept of Cystic FibrosisRoyal BromptonRoyal Brompton Campus





Nick Simmonds is Professor of Practice (Respiratory Medicine) at the National Heart and Lung Institute (NHLI), Imperial College London and Associate Director of the Adult CF Centre at the Royal Brompton Hospital, London. His main research interests include difficult CF diagnosis and the investigation of novel CF therapies. He has been a Principal Investigator on numerous global multicentre trials and is on the Executive Committee of the European Cystic Fibrosis Society (ECFS) Clinical Trials Network. He has extensive experience of novel diagnostic techniques and is the Vice Coordinator of the ECFS Diagnostic Network. He is also on the Registry Research Committee of the UK CF Registry, a role which promotes the use of registries to better understand outcomes in CF.



Castellani C, De Boeck K, De Wachter E, et al., 2022, ECFS standards of care on CFTR-related disorders: Updated diagnostic criteria., J Cyst Fibros

Tanner KT, Daniel RM, Bilton D, et al., 2022, Mediation of the total effect of cystic fibrosis-related diabetes on mortality: A UK Cystic Fibrosis Registry cohort study, Diabetic Medicine, Vol:39, ISSN:0742-3071

Stanford GE, Jones M, Charman SC, et al., 2022, Clinimetric analysis of outcome measures for airway clearance in people with cystic fibrosis: a systematic review, Therapeutic Advances in Respiratory Disease, Vol:16, ISSN:1753-4666, Pages:1-12

Davies J, Hughes D, Rosenthal M, et al., 2022, An invisible threat? Aspergillus positive cultures and co-infecting bacteria in airway sample, Journal of Cystic Fibrosis, ISSN:1569-1993

Cameron RA, Office D, Matthews J, et al., 2022, Treatment Preference Among People With Cystic Fibrosis: The Importance of Reducing Treatment Burden., Chest

More Publications